{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:05Z","timestamp":1789684985222,"version":"4.0.1"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,16]]},"DOI":"10.18632\/oncotarget.7032","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T22:23:43Z","timestamp":1453933423000},"page":"8321-8331","source":"Crossref","is-referenced-by-count":46,"title":["Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent<i>SETDB1<\/i>mutations in malignant pleural mesotheliomas"],"prefix":"10.18632","volume":"7","author":[{"given":"Hio Chung","family":"Kang","sequence":"first","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"},{"name":"Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"},{"name":"Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lee","sequence":"additional","affiliation":[{"name":"CureSeq Inc, Brisbane, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mendez","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Wansoo","family":"Kim","sequence":"additional","affiliation":[{"name":"CureSeq Inc, Brisbane, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavitt","family":"Woodard","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Hee","family":"Yoon","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Yu","family":"Jen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Tai","family":"Fang","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Jablons","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"},{"name":"Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA"},{"name":"Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11912-011-0177-9","article-title":"Malignant pleural mesothelioma","volume":"13","author":"Mason","year":"2011","journal-title":"Current Oncology Reports"},{"key":"2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0031-1272874","article-title":"Update on malignant pleural mesothelioma","volume":"32","author":"Kindler","year":"2011","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma","volume":"18","author":"Yang","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10147-011-0369-1","article-title":"Pathological and molecular biological approaches to early mesothelioma","volume":"17","author":"Nakano","year":"2012","journal-title":"International Journal of Clinical Oncology"},{"key":"5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11912-011-0172-1","article-title":"Medical treatment of mesothelioma: anything new?","volume":"13","author":"Kishimoto","year":"2011","journal-title":"Current Oncology Reports"},{"key":"6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"7","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"Giaccone","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/gcc.2870010207","article-title":"Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes","volume":"1","author":"Testa","year":"1989","journal-title":"Genes, Chromosomes and Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jaurand","year":"2012","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1997.91","article-title":"Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma","volume":"75","author":"Knuutila","year":"1997","journal-title":"British Journal of Cancer"},{"key":"11","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma","volume":"54","author":"Testa","year":"1994","journal-title":"Cancer Research"},{"key":"12","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Minna","year":"1995","journal-title":"Cancer Research"},{"key":"13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma","volume":"43","author":"Powell","year":"2011","journal-title":"Nature Genetics"},{"key":"14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Powers","year":"2011","journal-title":"Nature Genetics"},{"key":"15","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.0712399105","article-title":"Transcriptome sequencing of malignant pleural mesothelioma tumors","volume":"105","author":"Kingsmore","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ijc.29015","article-title":"Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI\/SNF genes","volume":"136","author":"Hashimoto-Tamaoki","year":"2015","journal-title":"International Journal of Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/gb-2011-12-9-r96","article-title":"First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum","volume":"12","author":"Teh","year":"2011","journal-title":"Genome Biology"},{"key":"18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Pass","year":"2015","journal-title":"Cancer Research"},{"key":"19","doi-asserted-by":"crossref","first-page":"e10612","DOI":"10.1371\/journal.pone.0010612","article-title":"Second generation sequencing of the mesothelioma tumor genome","volume":"5","author":"Sugarbaker","year":"2010","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"crossref","first-page":"e0119689","DOI":"10.1371\/journal.pone.0119689","article-title":"Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing","volume":"10","author":"Gown","year":"2015","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1038\/onc.2013.239","article-title":"Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis","volume":"33","author":"Esteller","year":"2014","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1021\/bi200192j","article-title":"Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain","volume":"50","author":"Daggett","year":"2011","journal-title":"Biochemistry"},{"key":"23","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.0607286103","article-title":"Structural basis for understanding oncogenic p53 mutations and designing rescue drugs","volume":"103","author":"Fersht","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"24","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1073\/pnas.97.13.7405","article-title":"Chromosome instability contributes to loss of heterozygosity in mice lacking p53","volume":"97","author":"Tischfield","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature09806","article-title":"The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset","volume":"471","author":"Turner","year":"2011","journal-title":"Nature"},{"key":"26","doi-asserted-by":"crossref","first-page":"E672","DOI":"10.1073\/pnas.1313580111","article-title":"Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer","volume":"111","author":"Wang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","article-title":"Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations","volume":"148","author":"Wang","year":"2012","journal-title":"Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0000000000000493","article-title":"Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing","volume":"10","author":"Yamada","year":"2015","journal-title":"Journal of Thoracic Oncology"},{"key":"29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Scagliotti","year":"2015","journal-title":"Journal of Thoracic Oncology"},{"key":"30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbrc.2015.08.065","article-title":"Analysis of the subcellular localization of the human histone methyltransferase SETDB1","volume":"465","author":"Doi","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"31","first-page":"1","article-title":"SETDB1 in Early Embryos and Embryonic Stem Cells","volume":"17","author":"Kang","year":"2015","journal-title":"Current Issues in Molecular Biology"},{"key":"32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3892\/ijo.2013.2150","article-title":"Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis","volume":"44","author":"Kim","year":"2014","journal-title":"International Journal of Oncology"},{"key":"33","first-page":"1900","article-title":"Development of a rapid and practical mutation screening assay for human lung adenocarcinoma","volume":"40","author":"Kim","year":"2012","journal-title":"International Journal of Oncology"},{"key":"34","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/ncomms2660","article-title":"Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas","volume":"4","author":"Balmain","year":"2013","journal-title":"Nature Communications"},{"key":"35","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Hakonarson","year":"2010","journal-title":"Nucleic Acids Research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:34:48Z","timestamp":1718325288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,2,16]]}},"alternative-id":["7032","26824986"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7032","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}